RU2001107005A - Биофлавоноиды в качестве агента, снижающего уровень глюкозы в крови - Google Patents
Биофлавоноиды в качестве агента, снижающего уровень глюкозы в кровиInfo
- Publication number
- RU2001107005A RU2001107005A RU2001107005/14A RU2001107005A RU2001107005A RU 2001107005 A RU2001107005 A RU 2001107005A RU 2001107005/14 A RU2001107005/14 A RU 2001107005/14A RU 2001107005 A RU2001107005 A RU 2001107005A RU 2001107005 A RU2001107005 A RU 2001107005A
- Authority
- RU
- Russia
- Prior art keywords
- group
- bioflavonoid
- alkoxy
- hydroxy
- aryloxy
- Prior art date
Links
- 210000004369 Blood Anatomy 0.000 title claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims 3
- 239000008280 blood Substances 0.000 title claims 3
- 239000008103 glucose Substances 0.000 title claims 3
- 229940083828 Bioflavonoid drugs for capillary stabilizing Drugs 0.000 title 1
- 229940093797 Bioflavonoids Drugs 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000004104 aryloxy group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 239000000419 plant extract Substances 0.000 claims 4
- 125000003368 amide group Chemical group 0.000 claims 3
- 239000000284 extract Substances 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical group 0.000 claims 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims 2
- AIONOLUJZLIMTK-AWEZNQCLSA-N Hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 claims 2
- FTVWIRXFELQLPI-ZDUSSCGKSA-N Naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 235000013311 vegetables Nutrition 0.000 claims 2
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 claims 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 claims 1
- 241000219051 Fagopyrum Species 0.000 claims 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims 1
- 229940025878 Hesperidin Drugs 0.000 claims 1
- QUQPHWDTPGMPEX-YEDPJISVSA-N Hesperidin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C[C@@H](c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 QUQPHWDTPGMPEX-YEDPJISVSA-N 0.000 claims 1
- DFPMSGMNTNDNHN-OHXUDFEXSA-N Naringin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(O)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 DFPMSGMNTNDNHN-OHXUDFEXSA-N 0.000 claims 1
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims 1
- 229960001285 Quercetin Drugs 0.000 claims 1
- 229940081967 Rutin Drugs 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive Effects 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000005201 cycloalkylcarbonyloxy group Chemical group 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 claims 1
- 229960004352 diosmin Drugs 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 235000010209 hesperetin Nutrition 0.000 claims 1
- 229960001587 hesperetin Drugs 0.000 claims 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000007625 naringenin Nutrition 0.000 claims 1
- 229940117954 naringenin Drugs 0.000 claims 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 claims 1
- 229940052490 naringin Drugs 0.000 claims 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims 1
- 239000000879 neohesperidine DC Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229930002344 quercetin Natural products 0.000 claims 1
- 235000005875 quercetin Nutrition 0.000 claims 1
- 229930002876 rutin Natural products 0.000 claims 1
- 235000005493 rutin Nutrition 0.000 claims 1
- 229960004555 rutoside Drugs 0.000 claims 1
Claims (11)
1. Применение биофлавоноида формулы (I) или растительного экстракта, содержащего биофлавоноид, для снижения уровня глюкозы в крови у млекопитающего
где каждый R1, R2, R3, R4, R5, R6, R7, R8 и R9 независимо каждый представляет водород; гидроксигруппу; C1-9 алкоксигруппу, необязательно замещенную одним или более заместителями, выбранными из группы, состоящей из гидрокси, С1-5алкокси, арилокси и фенильной группы, замещенной 1-3 заместителями, выбранными из группы, состоящей из гидрокси, алкокси, арилокси, галогена, нитро и амидогруппы; C5-9 циклоалкилоксигруппу, замещенную 1-3 заместителями, выбранными из группы, состоящей из гидрокси, алкокси, арилокси, галогена, нитро и амидогруппы; C5-9 циклоалкилкарбонилоксигруппу, замещенную 1-3 заместителями, выбранными из группы, состоящей из гидрокси, алкокси, арилокси, галогена, нитро и амидогруппы; C2-10 или C16-18 ацилоксигруппу, необязательно замещенную одним или более заместителями, выбранными из группы, состоящей из гидрокси, С1-5алкокси, арилокси и фенильной группы, замещенной 1-3 заместителями, выбранными из группы, состоящей из гидрокси, алкокси, арилокси, галогена, нитрогруппы; рутинозильную группу; или раминозильную группу; и
Х представляет простую или двойную связь.
2. Применение по п.1, где указанным млекопитающим является человек.
3. Применение по п.2, где эффективное количество биофлавоноида изменяется от 0,1 до 500 мг/кг массы тела в день.
4. Применение по п.1, где биофлавоноидом является гесперидин, гесперетин, нарингин, нарингенин, диосмин, рутин, кверцетин или их смесь.
5. Применение по п.1, где растительным экстрактом является овощной или фруктовый экстракт.
6. Применение по п.5, где овощным экстрактом является экстракт из побегов, семян, стеблей, листьев или цветков гречихи.
7. Применение по п.1, где биофлавоноид или растительный экстракт вводят в виде фармацевтической композиции.
8. Применение по п.1, где биофлавоноид или растительный экстракт вводят в виде добавки или диетической добавки в пищевой продукт или напиток.
9. Применение по п.8, где количество биофлавоноида в пищевом продукте составляет в пределах от 0,01 до 50 мас.%.
10. Применение по п.8, где количество биофлавоноида в напитке составляет от 200 до 1000 мг на 1000 мл напитка.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1998/37958 | 1998-09-15 | ||
KR1019980037958A KR20000019716A (ko) | 1998-09-15 | 1998-09-15 | 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2203050C2 RU2203050C2 (ru) | 2003-04-27 |
RU2001107005A true RU2001107005A (ru) | 2003-07-27 |
Family
ID=19550601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001107005/14A RU2203050C2 (ru) | 1998-09-15 | 1998-10-20 | Биофлавоноиды в качестве агента, снижающего уровень глюкозы в крови |
Country Status (8)
Country | Link |
---|---|
US (1) | US6096364A (ru) |
EP (1) | EP1113791A2 (ru) |
JP (1) | JP2002524480A (ru) |
KR (1) | KR20000019716A (ru) |
CN (1) | CN1322132A (ru) |
CA (1) | CA2342608A1 (ru) |
RU (1) | RU2203050C2 (ru) |
WO (1) | WO2000015174A2 (ru) |
Families Citing this family (143)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6987125B1 (en) * | 1998-10-06 | 2006-01-17 | The United States Of America As Represented By The Secretary Of Agriculture | Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones |
US20020068704A1 (en) * | 1999-04-05 | 2002-06-06 | Ziegler Randy H. | Compositions and methods for treatment of diabetes |
US6413558B1 (en) * | 1999-07-19 | 2002-07-02 | The Proctor & Gamble Co. | Compositions, kits, and methods for providing and maintaining energy and metal alertness |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
CN1109681C (zh) * | 2000-06-15 | 2003-05-28 | 宁夏大学 | 黄酮铬及其生产方法和用途 |
JP2011105763A (ja) * | 2000-06-21 | 2011-06-02 | Kao Corp | Ppar依存的遺伝子転写活性化剤 |
US20110171333A1 (en) * | 2000-12-05 | 2011-07-14 | Bryant Wadsworth | Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products |
AU2002308324B2 (en) * | 2001-05-02 | 2008-04-03 | Kgk Synergize Inc. | Polymethoxylated flavones for treating insulin resistance |
BRPI0210463A8 (pt) * | 2001-07-27 | 2017-07-25 | Merck Patent Ges Mit Beschraenkter Haftung | Extratos de bauhínia |
WO2003020026A1 (en) | 2001-08-31 | 2003-03-13 | Rutgers, The State University Of New Jersey | Methods for treating disorders using plant extracts |
WO2003022994A2 (en) * | 2001-09-06 | 2003-03-20 | Synorx, Inc. | Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
KR20050035142A (ko) * | 2001-10-11 | 2005-04-15 | 카네카 코포레이션 | 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법 |
US8129350B2 (en) | 2002-08-07 | 2012-03-06 | Queen Bioactives Pty Ltd | Method of lowering Glycaemic Index of foods |
US20050080024A1 (en) * | 2002-08-15 | 2005-04-14 | Joseph Tucker | Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
US20040033480A1 (en) * | 2002-08-15 | 2004-02-19 | Wong Norman C.W. | Use of resveratrol to regulate expression of apolipoprotein A1 |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
JPWO2005042508A1 (ja) * | 2003-11-04 | 2007-05-24 | 明治乳業株式会社 | 植物由来β3アドレナリン受容体作動性物質およびその利用 |
KR100658772B1 (ko) * | 2004-01-20 | 2006-12-15 | 씨제이 주식회사 | 초미세 인삼 분말을 이용한 음료 및 그 제조방법 |
CA2556331A1 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
JP4685363B2 (ja) * | 2004-03-31 | 2011-05-18 | 長田産業株式会社 | ケルセチン高濃度含有物の製造方法 |
AU2005247160A1 (en) * | 2004-05-26 | 2005-12-08 | Kgk Synergize Inc | Functional foods comprising flavonoids and tocotrienols and methods thereof |
AU2005247159B2 (en) * | 2004-05-26 | 2015-07-23 | Interhealth Nutraceuticals Incorporated | Pharmaceutical products for treating neoplastic disease and inflammation |
ZA200610168B (en) * | 2004-05-26 | 2008-06-25 | Kgk Synergize Inc | Compositions comprising flavonoids and tocotrienols and methods thereof |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
KR100728055B1 (ko) * | 2005-02-24 | 2007-06-13 | (주)바이오뉴트리젠 | 비만증 및 고지혈증 예방용 식품 |
EP2368442B1 (en) | 2005-07-27 | 2014-12-17 | Symrise AG | Use of hesperetin for enhancing the sweet taste |
JP2008133192A (ja) * | 2005-09-29 | 2008-06-12 | Kureha Corp | 抗糖尿病剤 |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
JP2007223914A (ja) * | 2006-02-21 | 2007-09-06 | Unitika Ltd | 経口投与組成物 |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US20070224301A1 (en) * | 2006-03-21 | 2007-09-27 | Ribnicky David M | Compounds from an extract of Artemisia and methods for treating disorders |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
ES2288122B1 (es) * | 2006-06-02 | 2008-10-01 | Furfural Español,Sa. | Composicion alimentaria funcional rica en compuestos fenolicos y uso de dicha composicion. |
US7993687B2 (en) * | 2006-07-12 | 2011-08-09 | Julianne Marie Kawa | Compositions and methods for management of diabetes |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
JP2008195719A (ja) * | 2007-01-19 | 2008-08-28 | Shonan Institute For Medical & Preventive Science | 血糖値上昇抑制剤 |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
ES2371393T3 (es) * | 2007-03-12 | 2011-12-30 | Zadec Aps | Extracto antidiabético de rooibos. |
US20110045108A1 (en) * | 2007-03-12 | 2011-02-24 | Zadec Aps | Anti-diabetic extract of honeybush |
CA2685031A1 (en) * | 2007-03-19 | 2008-09-25 | Atm Metabolics Lllp | Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
US10111608B2 (en) | 2007-04-14 | 2018-10-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130895A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
WO2008130897A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
ES2461090T3 (es) | 2007-04-14 | 2014-05-16 | Abbott Diabetes Care Inc. | Procedimiento y aparato para proporcionar tratamiento y control de datos en un sistema de comunicación médica |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US20080268069A1 (en) * | 2007-04-25 | 2008-10-30 | Ryusendo Co., Ltd. | Mixture having effect of improving insulin resistance, effect of suppressing body weight gain, and effect of preventing and improving fatty liver |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
JP2010531169A (ja) | 2007-06-21 | 2010-09-24 | アボット ダイアベティス ケア インコーポレイテッド | 健康監視装置 |
WO2008157820A1 (en) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8876755B2 (en) | 2008-07-14 | 2014-11-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
EP2183977A1 (en) | 2008-11-06 | 2010-05-12 | Unilever N.V. | Food product |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
JP2010222277A (ja) * | 2009-03-23 | 2010-10-07 | Kao Corp | 食後の血糖値上昇抑制剤 |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | METHOD AND SYSTEM FOR REAL-TIME CALIBRATION OF AN ANALYTICAL SENSOR WITH RETROACTIVE FILLING |
EP2432320A4 (en) * | 2009-05-20 | 2013-03-06 | Nutracryst Therapeutics Private Ltd | PHARMACEUTICAL CO-CRYSTALS OF QUERCÉTINE |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP4309580A3 (en) | 2009-07-23 | 2024-02-28 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
EP4276652A3 (en) | 2009-07-23 | 2024-01-31 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
WO2011026147A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US8514086B2 (en) | 2009-08-31 | 2013-08-20 | Abbott Diabetes Care Inc. | Displays for a medical device |
EP3001194B1 (en) | 2009-08-31 | 2019-04-17 | Abbott Diabetes Care, Inc. | Medical devices and methods |
EP2473099A4 (en) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | ANALYTICAL SUBSTANCE MONITORING SYSTEM AND METHODS OF MANAGING ENERGY AND NOISE |
EP2482720A4 (en) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | METHOD AND APPARATUS FOR PROVIDING NOTIFICATION FUNCTION IN SUBSTANCE MONITORING SYSTEMS |
US20110135783A1 (en) * | 2009-12-04 | 2011-06-09 | Ellen's Organics, Inc. | Fruit and vegetables powders with organic sugar alcohols |
RU2415610C1 (ru) * | 2009-12-09 | 2011-04-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище |
EP2359702B1 (en) * | 2010-01-22 | 2014-06-04 | Symrise AG | Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides |
US8916217B2 (en) | 2010-01-29 | 2014-12-23 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising HMB |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
PE20121729A1 (es) | 2010-01-29 | 2013-01-16 | Abbott Lab | Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb) de calcio |
EP2533787B1 (de) * | 2010-02-11 | 2015-03-25 | Dr. Willmar Schwabe GmbH & Co. KG | Verwendung von isorhamnetintriglycosiden |
US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
CN103037692B (zh) | 2010-05-20 | 2015-02-25 | 爱荷华大学研究基金会 | 用于抑制肌萎缩的方法 |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
CN102116772B (zh) * | 2010-09-28 | 2013-08-28 | 上海大学 | 二氢查尔酮化合物的筛选方法 |
EP2624745A4 (en) | 2010-10-07 | 2018-05-23 | Abbott Diabetes Care, Inc. | Analyte monitoring devices and methods |
WO2012097064A1 (en) * | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for controlling blood glucose |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
CN103619255B (zh) | 2011-02-28 | 2016-11-02 | 雅培糖尿病护理公司 | 与分析物监测装置关联的装置、系统和方法以及结合了它们的装置 |
RU2451506C1 (ru) * | 2011-06-02 | 2012-05-27 | Сергей Юрьевич Лешков | Комбинация для лечения сахарного диабета и его осложнений |
JP6001060B2 (ja) | 2011-06-06 | 2016-10-05 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 筋萎縮を阻害するための方法 |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
CN102772424B (zh) * | 2012-06-13 | 2014-01-08 | 浙江大学 | 新橙皮苷在制备防治糖尿病药物中的应用 |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
KR101628950B1 (ko) * | 2014-02-14 | 2016-06-09 | 경희대학교 산학협력단 | Rg3, 루틴 또는 그의 조합을 유효성분으로 포함하는 당뇨병전증, 당뇨병, 또는 당뇨병으로 인한 합병증의 예방 및 치료용 조성물 |
US20150272184A1 (en) | 2014-03-27 | 2015-10-01 | International Flavors & Fragrances Inc. | Naringenin and salts thereof for sweetness enhancement |
JP5996571B2 (ja) * | 2014-03-27 | 2016-09-21 | ナチュレワイズ バイオテック&メディカル コーポレーション | 糖尿病を調節するプレニルフラバノン化合物 |
CN104107269A (zh) * | 2014-05-21 | 2014-10-22 | 陕西科技大学 | 一种功能性降血糖保健品及其制备方法 |
CN108024765B (zh) | 2015-07-10 | 2021-06-11 | 雅培糖尿病护理公司 | 对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法 |
CN106924239A (zh) * | 2017-03-06 | 2017-07-07 | 龚* | 橙皮素用于制备防治糖尿病的药物的用途 |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
CN107325071A (zh) * | 2017-06-05 | 2017-11-07 | 浙江中医药大学 | 一种具有降血糖作用的山核桃叶球松素的制备方法和用途 |
CN107252440A (zh) * | 2017-06-05 | 2017-10-17 | 浙江中医药大学 | 一种具有降血糖作用的山核桃叶总黄酮的制备方法和用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH602778A5 (ru) * | 1975-05-16 | 1978-07-31 | Hommel Ag | |
US4705875A (en) * | 1984-06-13 | 1987-11-10 | Mitchell David C | Substituted fructose compounds and vitamin supplements and methods for making same |
JPS63104920A (ja) * | 1986-10-21 | 1988-05-10 | Tsumura & Co | アルド−スリダクタ−ゼ阻害剤 |
FR2633182B1 (fr) * | 1988-06-23 | 1993-07-23 | Beljanski Mirko | Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention |
JPH035423A (ja) * | 1989-06-01 | 1991-01-11 | Ichimaru Pharcos Co Ltd | フラボノイド含有過酸化脂質生成抑制剤 |
JP3060227B2 (ja) * | 1989-06-03 | 2000-07-10 | 株式会社林原生物化学研究所 | α―グリコシル ヘスペリジンとその製造方法並びに用途 |
JP3194145B2 (ja) * | 1989-09-28 | 2001-07-30 | 株式会社林原生物化学研究所 | 4G―α―D―グルコピラノシルルチンとその製造方法並びに用途 |
US5171573A (en) * | 1989-09-28 | 1992-12-15 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 4G -alpha-D-glucopyranosyl rutin, and its preparation and uses |
JP3060232B2 (ja) * | 1990-04-29 | 2000-07-10 | 株式会社林原生物化学研究所 | α―グリコシル ナリンジンとその製造方法並びに用途 |
JPH04243822A (ja) * | 1991-01-24 | 1992-08-31 | Tsumura & Co | カルシウム拮抗剤 |
JPH0725761A (ja) * | 1993-07-09 | 1995-01-27 | Kureha Chem Ind Co Ltd | 軟骨保護剤 |
FR2710844B1 (fr) * | 1993-10-07 | 1995-12-29 | Bidel Christian Georges | Composition pour le traitement ou la prévention de l'herpès. |
JPH08283154A (ja) * | 1995-04-12 | 1996-10-29 | Nippon Shinyaku Co Ltd | 脂質代謝改善剤 |
JP3557711B2 (ja) * | 1995-04-12 | 2004-08-25 | 日本新薬株式会社 | 脂質代謝改善に有効な食品及び製法 |
JP4376977B2 (ja) * | 1995-09-22 | 2009-12-02 | 日本製粉株式会社 | リパーゼ阻害剤、食品添加物及び食品 |
-
1998
- 1998-09-15 KR KR1019980037958A patent/KR20000019716A/ko not_active Application Discontinuation
- 1998-10-20 CN CN98814241A patent/CN1322132A/zh active Pending
- 1998-10-20 JP JP2000569759A patent/JP2002524480A/ja active Pending
- 1998-10-20 CA CA002342608A patent/CA2342608A1/en not_active Abandoned
- 1998-10-20 WO PCT/KR1998/000325 patent/WO2000015174A2/en not_active Application Discontinuation
- 1998-10-20 RU RU2001107005/14A patent/RU2203050C2/ru not_active IP Right Cessation
- 1998-10-20 EP EP98951778A patent/EP1113791A2/en not_active Withdrawn
- 1998-10-22 US US09/177,463 patent/US6096364A/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001107005A (ru) | Биофлавоноиды в качестве агента, снижающего уровень глюкозы в крови | |
US6096364A (en) | Method for lowering blood glucose level by the administration of bioflavonoid | |
US6133241A (en) | Bioflavonoids as plasma high density lipoprotein level increasing agent | |
Bhadoriya et al. | Tamarindus indica: Extent of explored potential | |
Hässig et al. | Flavonoids and tannins: plant-based antioxidants with vitamin character | |
Cook et al. | Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources | |
CN101553137B (zh) | 具有高多酚含量的苹果 | |
Arnason et al. | Use of plants for food and medicine by Native Peoples of eastern Canada | |
JP2009286796A (ja) | 抗新形成性のココア抽出物の製造および使用方法 | |
WO2001051043A2 (en) | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols | |
Abreu et al. | Vaccinium (Ericaceae): Ethnobotany and pharmacological potentials. | |
BG103969A (en) | C-4"-substituted macrolide derivatives | |
JP4393777B2 (ja) | 抗ヘリコバクター・ピロリ用組成物 | |
Rajesh | Medicinal benefits of Musa paradisiaca (Banana) | |
RU2006131758A (ru) | Композиция для предупреждения простуды | |
Al-Shahat et al. | Moringa oleifera: a review of pharmacological benefits | |
KR100654586B1 (ko) | 숙취해소용 조성물 및 그를 포함하는 음료 | |
KR100915848B1 (ko) | 해삼용 사료첨가물 | |
WO2009109573A1 (de) | Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen | |
US3456057A (en) | Pharmaceutical compositions and methods utilizing 3-aminotricyclo(4.3.1.1**3.8)undecanes | |
WO1987003481A1 (en) | Anthracycline type antitumor agents with l-ascorbic acid | |
RU2122421C1 (ru) | Фитоконцентрат лечебно-профилактического действия при заболеваниях в области почек и мочевого пузыря | |
RU2122422C1 (ru) | Фитоконцентрат лечебно-профилактического действия для лиц с заболеваниями предстательной железы | |
RU2001113082A (ru) | Состав для изготовления драже | |
KR100908038B1 (ko) | 당뇨성 합병증 예방 또는 치료용 곰피 추출물 |